iC³: Innovation = Capital x Collaboration x Commercialization

The 2025 iC³ Life Science & Healthcare Innovation Summit is more than just an event—it is a glimpse into the future of life sciences and healthcare. Celebrating “10 Years and Beyond” of this premier event, we spotlight the transformative convergence of biology, technology, and artificial intelligence (AI), exploring how these advancements drive global breakthroughs.

Join industry leaders, innovators, and stakeholders to discuss the opportunities ahead, collaborate on solutions, and accelerate innovation that transcends borders and disciplines.

Be part of shaping the next decade of life sciences.

Artificial Intelligence (AI) is driving the next wave of innovation in biotech, unlocking new possibilities in drug discovery, diagnostics, and personalized medicine. This session will explore how AI is accelerating research, improving outcomes, and reshaping the biotech landscape.

Discover the transformative impact of AI technologies and how they are paving the way for a new era in biotechnology.

As global health concerns evolve—from aging and health span to public health emergencies to biomanufacturing vulnerabilities—America’s ability to respond with speed and precision depends on strong, agile innovation ecosystems. This panel features leaders from Advanced Technology International (ATI)’s diverse portfolio of medical and health focused consortia, which represents a cross-sector engine for innovation—accelerating the development and delivery of medical advancements, diagnostics, secure supply chains, and scalable biomanufacturing.

Panelists will share how these novel public-private partnership models are transforming the government’s ability to identify needs, engage nontraditional performers, and deploy real-world solutions to meet national health priorities.

A vibrant life sciences community depends on the power of the place. Regional leaders have recognized the benefit of bringing together resources, including research institutions, entrepreneurs, corporate partners, investors and nonprofits, to promote interactions -- some unexpected -- and spur growth.

North Texas has seen a wave of place-based innovation in life sciences. Recent successes include Pegasus Park in Dallas, which connects academic researchers, startups, investors and ecosystem partners; and Texas A&M's new campus in Fort Worth, which will bring industry together with multiple universities, departments and state agencies in an innovation district to transform the city's downtown.

As federal priorities shift, access to non-dilutive funding and preclinical support is more critical—and complex—than ever. This session brings together experts from D.C., academia, and state agencies to demystify the evolving landscape.

Learn how to navigate federal grants, tap into emerging resources, and align your work for long-term, mission-driven growth.

Patient advocacy ensures individuals receive the care and support they need, but true impact happens when businesses integrate patient needs into their strategies.

This session will explore how advocacy and patient-centered business models drive better healthcare outcomes.

As biotech and life sciences accelerate driven by AI, personalized medicine, and advanced therapeutics—the demand for skilled, future-ready talent is surging.

This session explores how North Texas is connecting education with opportunity to build a strong regional talent pipeline and position itself as a full-spectrum innovation hub.